These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

134 related articles for article (PubMed ID: 10022215)

  • 21. Differentiating new marijuana use from residual drug excretion in occasional marijuana users.
    Huestis MA; Cone EJ
    J Anal Toxicol; 1998 Oct; 22(6):445-54. PubMed ID: 9788519
    [TBL] [Abstract][Full Text] [Related]  

  • 22. An investigation of normal urine with a creatinine concentration under the cutoff of 20 mg/dL for specimen validity testing in a toxicology laboratory.
    Holden B; Guice EA
    J Forensic Sci; 2014 May; 59(3):806-10. PubMed ID: 24502684
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Urine pH: the effects of time and temperature after collection.
    Cook JD; Strauss KA; Caplan YH; Lodico CP; Bush DM
    J Anal Toxicol; 2007 Oct; 31(8):486-96. PubMed ID: 17988463
    [TBL] [Abstract][Full Text] [Related]  

  • 24. The effects of adulterating agents on FPIA analysis of urine for drugs of abuse.
    Schwarzhoff R; Cody JT
    J Anal Toxicol; 1993; 17(1):14-7. PubMed ID: 8429620
    [TBL] [Abstract][Full Text] [Related]  

  • 25. The measurement of nitrite in adulterated urine samples by high-performance ion chromatography.
    Singh J; Elberling JA; Hemphill DG; Holmstrom J
    J Anal Toxicol; 1999; 23(3):137-40. PubMed ID: 10369320
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Determination of five abused drugs in nitrite-adulterated urine by immunoassays and gas chromatography-mass spectrometry.
    Tsai SC; ElSohly MA; Dubrovsky T; Twarowska B; Towt J; Salamone SJ
    J Anal Toxicol; 1998 Oct; 22(6):474-80. PubMed ID: 9788522
    [TBL] [Abstract][Full Text] [Related]  

  • 27. [The detection of amphetamines in urine samples using immunochromatographic test strips].
    Shanin IA; Khan OIu; Petukhov AE; Smirnov AV; Eremin SA
    Sud Med Ekspert; 2012; 55(4):33-7. PubMed ID: 23008958
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Nitrite adulteration of workplace urine drug-testing specimens. I. Sources and associated concentrations of nitrite in urine and distinction between natural sources and adulteration.
    Urry FM; Komaromy-Hiller G; Staley B; Crockett DK; Kushnir M; Nelson G; Struempler RE
    J Anal Toxicol; 1998; 22(2):89-95. PubMed ID: 9547404
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Urinalysis.
    Wilson LA
    Nurs Stand; 2005 May 11-17; 19(35):51-4. PubMed ID: 15915958
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Beating the system: a study of a creatinine assay and its efficacy in authenticating human urine specimens.
    Villena VP
    J Anal Toxicol; 2010; 34(1):39-44. PubMed ID: 20109301
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Determination of chromate adulteration of human urine by automated colorimetric and capillary ion electrophoretic analyses.
    Ferslew KE; Nicolaides AN; Robert TA
    J Anal Toxicol; 2003; 27(1):36-9. PubMed ID: 12587681
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Urine drug screening: a valuable office procedure.
    Standridge JB; Adams SM; Zotos AP
    Am Fam Physician; 2010 Mar; 81(5):635-40. PubMed ID: 20187600
    [TBL] [Abstract][Full Text] [Related]  

  • 33. The detection of drugs of abuse in liquid perspiration.
    Crouch DJ; Cook RF; Trudeau JV; Dove DC; Robinson JJ; Webster HL; Fatah AA
    J Anal Toxicol; 2001 Oct; 25(7):625-7. PubMed ID: 11599612
    [No Abstract]   [Full Text] [Related]  

  • 34. Urine drug screening: A guide to monitoring Tx with controlled substances.
    Hayes J; Fox K
    J Fam Pract; 2021 Apr; 70(3):112-120. PubMed ID: 34314334
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Novel spot tests for detecting the presence of zinc sulfate in urine, a newly introduced urinary adulterant to invalidate drugs of abuse testing.
    Welsh KJ; Dierksen JE; Actor JK; Dasgupta A
    Am J Clin Pathol; 2013 Oct; 140(4):572-8. PubMed ID: 24045556
    [TBL] [Abstract][Full Text] [Related]  

  • 36. The U.S. Mandatory Guidelines for Federal Workplace Drug Testing Programs: current status and future considerations.
    Bush DM
    Forensic Sci Int; 2008 Jan; 174(2-3):111-9. PubMed ID: 17434274
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Hair analysis. New laboratory ability to test for substance use.
    McPhillips MA; Strang J; Barnes TR
    Br J Psychiatry; 1998 Oct; 173():287-90. PubMed ID: 9926030
    [No Abstract]   [Full Text] [Related]  

  • 38. Importance of creatinine analyses of urine when screening for abused drugs.
    Lafolie P; Beck O; Blennow G; Boréus L; Borg S; Elwin CE; Karlsson L; Odelius G; Hjemdahl P
    Clin Chem; 1991 Nov; 37(11):1927-31. PubMed ID: 1934467
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Urine testing for cocaine abuse: metabolic and excretion patterns following different routes of administration and methods for detection of false-negative results.
    Cone EJ; Sampson-Cone AH; Darwin WD; Huestis MA; Oyler JM
    J Anal Toxicol; 2003 Oct; 27(7):386-401. PubMed ID: 14606991
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Toxicological screening for drugs of abuse in samples adulterated with household chemicals.
    Uebel RA; Wium CA
    S Afr Med J; 2002 Jul; 92(7):547-9. PubMed ID: 12197198
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 7.